Literature DB >> 32437855

ALS and Parkinson's disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons.

Sandra Harjuhaahto1, Tiina S Rasila1, Svetlana M Molchanova2, Rosa Woldegebriel1, Jouni Kvist1, Svetlana Konovalova1, Markus T Sainio1, Jana Pennonen1, Rubén Torregrosa-Muñumer1, Hazem Ibrahim1, Timo Otonkoski1, Tomi Taira3, Emil Ylikallio4, Henna Tyynismaa5.   

Abstract

Mitochondrial intermembrane space proteins CHCHD2 and CHCHD10 have roles in motor neuron diseases such as amyotrophic lateral sclerosis, spinal muscular atrophy and axonal neuropathy and in Parkinson's disease. They form a complex of unknown function. Here we address the importance of these two proteins in human motor neurons. We show that gene edited human induced pluripotent stem cells (iPSC) lacking either CHCHD2 or CHCHD10 are viable and can be differentiated into functional motor neurons that fire spontaneous and evoked action potentials. Mitochondria in knockout iPSC and motor neurons sustain ultrastructure but show increased proton leakage and respiration, and reciprocal compensatory increases in CHCHD2 or CHCHD10. Knockout motor neurons have largely overlapping transcriptome profiles compared to isogenic control line, in particular for synaptic gene expression. Our results show that the absence of either CHCHD2 or CHCHD10 alters mitochondrial respiration in human motor neurons, inducing similar compensatory responses. Thus, pathogenic mechanisms may involve loss of synaptic function resulting from defective energy metabolism.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALS; CHCHD10; CHCHD2; CMT2; CRISPR/Cas9; Induced pluripotent stem cell; Mitochondria; Motor neuron differentiation; RNA sequencing; SMAJ

Mesh:

Substances:

Year:  2020        PMID: 32437855     DOI: 10.1016/j.nbd.2020.104940

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  11 in total

Review 1.  Energy matters: presynaptic metabolism and the maintenance of synaptic transmission.

Authors:  Sunan Li; Zu-Hang Sheng
Journal:  Nat Rev Neurosci       Date:  2021-11-15       Impact factor: 34.870

2.  Mouse midbrain dopaminergic neurons survive loss of the PD-associated mitochondrial protein CHCHD2.

Authors:  Mai K Nguyen; Kevin McAvoy; Szu-Chi Liao; Zak Doric; Iris Lo; Huihui Li; Giovanni Manfredi; Ken Nakamura
Journal:  Hum Mol Genet       Date:  2022-05-04       Impact factor: 5.121

Review 3.  Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.

Authors:  Teresa R Kee; Pamela Espinoza Gonzalez; Jessica L Wehinger; Mohammed Zaheen Bukhari; Aizara Ermekbaeva; Apoorva Sista; Peter Kotsiviras; Tian Liu; David E Kang; Jung-A A Woo
Journal:  Front Aging Neurosci       Date:  2021-04-22       Impact factor: 5.750

4.  Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease.

Authors:  Xiaodan Liu; Qilong Wang; Ying Yang; Tessandra Stewart; Min Shi; David Soltys; Genliang Liu; Eric Thorland; Eugene M Cilento; Yiran Hou; Zongran Liu; Tao Feng; Jing Zhang
Journal:  Acta Neuropathol Commun       Date:  2021-03-08       Impact factor: 7.801

5.  Neurofilament Light Regulates Axon Caliber, Synaptic Activity, and Organelle Trafficking in Cultured Human Motor Neurons.

Authors:  Markus T Sainio; Tiina Rasila; Svetlana M Molchanova; Julius Järvilehto; Rubén Torregrosa-Muñumer; Sandra Harjuhaahto; Jana Pennonen; Nadine Huber; Sanna-Kaisa Herukka; Annakaisa Haapasalo; Henrik Zetterberg; Tomi Taira; Johanna Palmio; Emil Ylikallio; Henna Tyynismaa
Journal:  Front Cell Dev Biol       Date:  2022-02-14

6.  Serum Creatine, Not Neurofilament Light, Is Elevated in CHCHD10-Linked Spinal Muscular Atrophy.

Authors:  Julius Järvilehto; Sandra Harjuhaahto; Edouard Palu; Mari Auranen; Jouni Kvist; Henrik Zetterberg; Johanna Koskivuori; Marko Lehtonen; Anna Maija Saukkonen; Manu Jokela; Emil Ylikallio; Henna Tyynismaa
Journal:  Front Neurol       Date:  2022-02-17       Impact factor: 4.003

7.  Chchd10 is dispensable for myogenesis but critical for adipose browning.

Authors:  Wei Xia; Jiamin Qiu; Ying Peng; Madigan M Snyder; Lijie Gu; Kuilong Huang; Nanjian Luo; Feng Yue; Shihuan Kuang
Journal:  Cell Regen       Date:  2022-04-01

8.  Threshold of heteroplasmic truncating MT-ATP6 mutation in reprogramming, Notch hyperactivation and motor neuron metabolism.

Authors:  Sebastian Kenvin; Ruben Torregrosa-Muñumer; Marco Reidelbach; Jana Pennonen; Jeremi J Turkia; Erika Rannila; Jouni Kvist; Markus T Sainio; Nadine Huber; Sanna-Kaisa Herukka; Annakaisa Haapasalo; Mari Auranen; Ras Trokovic; Vivek Sharma; Emil Ylikallio; Henna Tyynismaa
Journal:  Hum Mol Genet       Date:  2022-03-21       Impact factor: 6.150

Review 9.  CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics.

Authors:  Tirthankar Sen; Rajkumar P Thummer
Journal:  Neurotox Res       Date:  2022-08-31       Impact factor: 3.978

Review 10.  PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson's Disease.

Authors:  Wen Li; YuHong Fu; Glenda M Halliday; Carolyn M Sue
Journal:  Front Cell Dev Biol       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.